117 related articles for article (PubMed ID: 36811214)
1. Association between residual islet beta-cell function and achieving the target of time in range in inpatients with type 2 diabetes undergoing antidiabetic treatment: An observation study.
Xia Z; You W; Li Y; Li F; Hao S; Sun Y; Li N; Lin L; Dou J; Su X; Zhai Q; Zuo Y; Zhang Y; Gaisano HY; Zheng D; He Y; Jiang J
Diabetes Obes Metab; 2023 Jun; 25(6):1714-1722. PubMed ID: 36811214
[TBL] [Abstract][Full Text] [Related]
2. Glycaemia in low-premixed insulin analogue type 2 diabetes patients in a real-world setting: are the CGM targets met?
Krajnc M; Kravos Tramšek NA
Eur J Med Res; 2023 Mar; 28(1):111. PubMed ID: 36882852
[TBL] [Abstract][Full Text] [Related]
3. Comparing the effectiveness of continuous subcutaneous insulin infusion with multiple daily insulin injection for patients with type 1 diabetes mellitus evaluated by retrospective continuous glucose monitoring: A real-world data analysis.
Keyu G; Jiaqi L; Liyin Z; Jianan Y; Li F; Zhiyi D; Qin Z; Xia L; Lin Y; Zhiguang Z
Front Public Health; 2022; 10():990281. PubMed ID: 36091534
[TBL] [Abstract][Full Text] [Related]
4. Time in range assessed by capillary blood glucose in relation to insulin sensitivity and β-cell function in patients with type 2 diabetes mellitus: A cross-sectional study in China.
Ye J; Deng J; Liang W; Luo H; Mei W; Liu L; Wang M; Shu Y
J Diabetes Investig; 2022 Nov; 13(11):1825-1833. PubMed ID: 35739637
[TBL] [Abstract][Full Text] [Related]
5. Association of Body Fat Percentage with Time in Range Generated by Continuous Glucose Monitoring during Continuous Subcutaneous Insulin Infusion Therapy in Type 2 Diabetes.
Ruan Y; Zhong J; Chen R; Zhang Z; Liu D; Sun J; Chen H
J Diabetes Res; 2021; 2021():5551216. PubMed ID: 34136580
[TBL] [Abstract][Full Text] [Related]
6. Effects of Continuous Glucose Monitoring on Metrics of Glycemic Control in Diabetes: A Systematic Review With Meta-analysis of Randomized Controlled Trials.
Maiorino MI; Signoriello S; Maio A; Chiodini P; Bellastella G; Scappaticcio L; Longo M; Giugliano D; Esposito K
Diabetes Care; 2020 May; 43(5):1146-1156. PubMed ID: 32312858
[TBL] [Abstract][Full Text] [Related]
7. Individualization of recommendations from the international consensus on continuous glucose monitoring-derived metrics in Japanese children and adolescents with type 1 diabetes.
Urakami T; Yoshida K; Kuwabara R; Mine Y; Aoki M; Suzuki J; Morioka I
Endocr J; 2020 Oct; 67(10):1055-1062. PubMed ID: 32565500
[TBL] [Abstract][Full Text] [Related]
8. [The appropriate cut-off point of time in range (TIR) for evaluating glucose control in type 2 diabetes mellitus].
Dai DJ; Lu JY; Zhang L; Shen Y; Mo YF; Lu W; Zhu W; Bao YQ; Zhou J
Zhonghua Yi Xue Za Zhi; 2020 Oct; 100(38):2990-2996. PubMed ID: 33086449
[No Abstract] [Full Text] [Related]
9. An Assessment of Clinical Continuous Glucose Monitoring Targets for Older and High-Risk People Living with Type 1 Diabetes.
O'Neal DN; Cohen O; Vogrin S; Vigersky RA; Jenkins AJ;
Diabetes Technol Ther; 2023 Feb; 25(2):108-115. PubMed ID: 36315189
[No Abstract] [Full Text] [Related]
10. The association between time in the glucose target range and abnormal ankle-brachial index: a cross-sectional analysis.
Wei Y; Liu C; Liu Y; Zhang Z; Feng Z; Yang X; Liu J; Lei H; Zhou H; Shen Q; Lu B; Gu P; Shao J
Cardiovasc Diabetol; 2022 Dec; 21(1):281. PubMed ID: 36514151
[TBL] [Abstract][Full Text] [Related]
11. One-year follow-up comparison of two hybrid closed-loop systems in Italian children and adults with type 1 diabetes.
Bassi M; Patti L; Silvestrini I; Strati MF; Ponzano M; Minuto N; Maggi D
Front Endocrinol (Lausanne); 2023; 14():1099024. PubMed ID: 36777356
[TBL] [Abstract][Full Text] [Related]
12. Continuous glucose monitoring metrics (Mean Glucose, time above range and time in range) are superior to glycated haemoglobin for assessment of therapeutic efficacy.
Rodbard D
Diabetes Obes Metab; 2023 Feb; 25(2):596-601. PubMed ID: 36314133
[TBL] [Abstract][Full Text] [Related]
13. Glycemic control metrics using flash glucose monitoring and hospital complications in patients with COVID-19.
Gómez AM; Henao DC; Muñoz OM; Aschner P; Yepes CA; Jojoa R; Kerguelen A; Parra D; Jaramillo P; Umpierrez GE
Diabetes Metab Syndr; 2021; 15(2):499-503. PubMed ID: 33662836
[TBL] [Abstract][Full Text] [Related]
14. Higher systolic blood pressure is specifically associated with better islet beta-cell function in T2DM patients with high glycemic level.
Xia Z; Song L; Fang D; You W; Li F; Zheng D; Li Y; Lin L; Dou J; Su X; Zhai Q; Zuo Y; Zhang Y; Gaisano HY; Jiang J; He Y
Cardiovasc Diabetol; 2022 Dec; 21(1):283. PubMed ID: 36536433
[TBL] [Abstract][Full Text] [Related]
15. The relationship between glycosylated hemoglobin, time-in-range and glycemic variability in type 1 diabetes patients under flash glucose monitoring.
Díaz-Soto G; Bahíllo-Curieses MP; Jimenez R; Nieto MO; Gomez E; Torres B; López Gomez JJ; de Luis D
Endocrinol Diabetes Nutr (Engl Ed); 2021; 68(7):465-471. PubMed ID: 34863411
[TBL] [Abstract][Full Text] [Related]
16. Association Between Continuous Glucose Monitoring-Derived Time in Range, Other Core Metrics, and Albuminuria in Type 2 Diabetes.
Yoo JH; Choi MS; Ahn J; Park SW; Kim Y; Hur KY; Jin SM; Kim G; Kim JH
Diabetes Technol Ther; 2020 Oct; 22(10):768-776. PubMed ID: 32167394
[No Abstract] [Full Text] [Related]
17. Feasibility of Real-Time Continuous Glucose Monitoring Telemetry System in an Inpatient Diabetes Unit: A Pilot Study.
Dillmann C; Amoura L; Fall Mostaine F; Coste A; Bounyar L; Kessler L
J Diabetes Sci Technol; 2022 Jul; 16(4):955-961. PubMed ID: 33660531
[TBL] [Abstract][Full Text] [Related]
18. Predictors of time in target glucose range in real-world users of the MiniMed 780G system.
Castañeda J; Mathieu C; Aanstoot HJ; Arrieta A; Da Silva J; Shin J; Cohen O
Diabetes Obes Metab; 2022 Nov; 24(11):2212-2221. PubMed ID: 35791621
[TBL] [Abstract][Full Text] [Related]
19. Use of Real-Time Continuous Glucose Monitoring Improves Glycemic Control and Other Clinical Outcomes in Type 2 Diabetes Patients Treated with Less Intensive Therapy.
Grace T; Salyer J
Diabetes Technol Ther; 2022 Jan; 24(1):26-31. PubMed ID: 34524013
[No Abstract] [Full Text] [Related]
20. Positioning time in range in diabetes management.
Advani A
Diabetologia; 2020 Feb; 63(2):242-252. PubMed ID: 31701199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
